Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Screening for Conditions by Electronic Nose Technology…

U.S. National Institutes of Health·United States of America

Screening for Conditions by Electronic Nose Technology (SCENT III) (Clinical Trial Not Allowed)

Closes 7/22/2026$500k – $2MGrants Notice
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The National Institutes of Health is seeking to develop electronic nose technologies for disease diagnosis and monitoring. This grant aims to improve the translation of existing knowledge for the prevention and treatment of various diseases. The ideal applicant will have experience in developing biosensing technologies and systems engineering. Key aspects of the job include: • Developing electronic nose technologies that mimic the olfactory system • Creating a robust diagnostic platform subject to validation and regulatory approval • Improving sensing, detection, and analytical technologies for integration into tools for disease diagnosis and monitoring • Complementing traditional blood analysis and other invasive procedures to monitor the onset, progression, and resolution of disease

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Contact

Leah Croucher(Program Contact)

[email protected]

(240) 701-2580

Key dates

Opened
9/29/2025
Closes
7/22/2026
Projected award
4/5/2027
Duration
4 years

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541714
Solicitation №
RFA-TR-26-001

Budget estimate

$500,000 – $2,000,000

The estimated budget range for this grant is between $500,000 and $2,000,000. This estimation is based on the fact that the National Institutes of Health typically awards grants in this range for research and development projects, especially those involving innovative technologies like electronic nose systems. Factors that may influence the likely payment range include the scope of the project, the experience and qualifications of the applicant, and the specific requirements of the grant.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 69%

Transformative Non-Invasive/Minimally Invasive Technologies for Imaging the Olfactory System Across Scales (R01 CT Optional)

Closes 8/21/2028Opened 7/17/2025

U.S. National Institutes of Health·United States of America

69% match

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

Closes 2/7/2027Opened 12/8/2025

U.S. National Institutes of Health·United States of America

69% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. National Institutes of Health·United States of America

68% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

68% match

Limited Competition: Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional)

Closes 9/25/2028Opened 6/9/2025

City of Ann Arbor·Michigan

68% match

Testing of Odor-Reducing Chemical Treatment for Municipal Sludge

Closes 11/18/2026Opened 10/22/2026

U.S. Department Of Defense·Texas

68% match

Microbial Identification System (MIS)

Closes 4/3/2027Opened 3/20/2025

U.S. National Institutes of Health·United States of America

68% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. National Institutes of Health·United States of America

68% match

Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed)

Closes 10/9/2028Opened 4/9/2026

U.S. National Institutes of Health·United States of America

67% match

NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)

Closes 12/1/2030Opened 2/27/2026

U.S. Food and Drug Administration·United States of America

67% match

Identification of Drug-related and Formulation-Related Factors that Result in Alcohol Dose Dumping of Modified Release Oral Drug Products (U01) Clinical Trial Not Allowed

Rolling / TBD closeOpened 11/24/2023

U.S. National Institutes of Health·United States of America

67% match

Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)

Closes 12/23/2027Opened 11/22/2024

U.S. National Institutes of Health·United States of America

67% match

Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 10/30/2024

U.S. National Institutes of Health·United States of America

67% match

NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)

Closes 5/25/2029Opened 6/16/2025

U.S. National Institutes of Health·United States of America

67% match

Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)

Closes 1/7/2028Opened 3/25/2021

U.S. Food and Drug Administration·United States of America

67% match

Cooperative Agreement to Support a Human Abuse Potential Study of Botanical Kratom (U01 Clinical Trial Required)

Rolling / TBD closeOpened 11/24/2023

U.S. Department Of Homeland Security·Virginia

67% match

Air Cargo Screening Qualification Test Process Guide

Closes 4/29/2031Opened 4/30/2026

Iowa State University·Iowa

67% match

Blood Spot and Dried Urine Testing

Closes 11/6/2026Opened 10/23/2026

U.S. National Institutes of Health·United States of America

67% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

67% match

Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed)

Closes 11/23/2026Opened 5/28/2025

U.S. National Institutes of Health·United States of America

67% match

Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)

Closes 12/23/2027Opened 11/22/2024

U.S. National Institutes of Health·United States of America

67% match

Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)

Closes 1/6/2028Opened 12/22/2021

Michigan Department of Health and Human Services – Bureau of Laboratories·Michigan

67% match

Mayo Medical Laboratories (MML)- Second tier testing for NBS

Closes 11/2/2026Opened 10/26/2026

U.S. National Institutes of Health·United States of America

67% match

Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)

Closes 9/10/2027Opened 12/13/2024

U.S. National Institutes of Health·United States of America

67% match

NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)

Closes 3/16/2027Opened 11/3/2023